anmelden
FTSE All-Share
5.479,78
PKT
-90,59
PKT
-1,63
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 31.05.22 | Unilever Sector Perform | RBC Capital Markets | |
| 31.05.22 | GSK Neutral | UBS AG | |
| 31.05.22 | Unilever Underweight | JP Morgan Chase & Co. | |
| 30.05.22 | HSBC Hold | Deutsche Bank AG | |
| 30.05.22 | Barclays Hold | Deutsche Bank AG | |
| 27.05.22 | GSK Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.05.22 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.05.22 | Vodafone Group Buy | UBS AG | |
| 27.05.22 | Prudential Buy | UBS AG | |
| 27.05.22 | Vodafone Group Buy | Deutsche Bank AG | |
| 27.05.22 | Diageo Market-Perform | Bernstein Research | |
| 26.05.22 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 26.05.22 | BP Hold | Jefferies & Company Inc. | |
| 26.05.22 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 26.05.22 | BP Outperform | RBC Capital Markets | |
| 26.05.22 | GSK Buy | Jefferies & Company Inc. | |
| 26.05.22 | BP Overweight | JP Morgan Chase & Co. | |
| 26.05.22 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 25.05.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 25.05.22 | Vodafone Group Overweight | Barclays Capital | |
| 25.05.22 | BAT Buy | Goldman Sachs Group Inc. | |
| 24.05.22 | Barclays Outperform | Credit Suisse Group | |
| 20.05.22 | Diageo Market-Perform | Bernstein Research | |
| 19.05.22 | Rio Tinto Hold | Deutsche Bank AG | |
| 19.05.22 | HSBC Neutral | JP Morgan Chase & Co. | |
| 19.05.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 19.05.22 | Barclays Neutral | JP Morgan Chase & Co. | |
| 19.05.22 | GSK Hold | Deutsche Bank AG | |
| 18.05.22 | Vodafone Group Buy | UBS AG | |
| 18.05.22 | Vodafone Group Buy | Deutsche Bank AG | |
| 18.05.22 | Vodafone Group Overweight | Barclays Capital | |
| 18.05.22 | Vodafone Group Outperform | Credit Suisse Group | |
| 17.05.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 17.05.22 | Vodafone Group Hold | Jefferies & Company Inc. | |
| 17.05.22 | Vodafone Group Conviction Buy List | Goldman Sachs Group Inc. | |
| 17.05.22 | Vodafone Group Overweight | Barclays Capital | |
| 17.05.22 | Vodafone Group Overweight | JP Morgan Chase & Co. | |
| 17.05.22 | Vodafone Group Buy | UBS AG | |
| 16.05.22 | Vodafone Group Buy | UBS AG | |
| 16.05.22 | Vodafone Group Overweight | JP Morgan Chase & Co. |